Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11413296
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal trac
granted patentUS 11414423
Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles for treating brain disorders
granted patentUS 11413278
Compounds and methods for promoting stress resistance
granted patentUS 11407649
Cerium (III) carbonate formulations
granted patentUS 11407990
Fusion proteins and methods for site-directed genome editing
granted patentUS 11407998
Twist signaling inhibitor compositions and methods of using the same
granted patentUS 11406597
Fusogenic liposome-coated porous silicon nanoparticles
granted patentUS 11406721
Compositions and methods for imaging cell populations
granted patentUS 11401532
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 11400098
Method of treating microbial infections
granted patentUS 11401332
Proteolytically cleavable chimeric polypeptides and methods of use thereof
granted patentUS 11400104
Skeletal removal of bisphosphonates
granted patentUS 11400284
Method of transcutaneous electrical spinal cord stimulation for facilitation of locomotion
granted patentUS 11400116
Systems and methods for targeting cancer cells
granted patentUS 11389396
Tumescent antibiotic injection for treatment of chronic skin and soft tissue infections
granted patentUS 11390646
Structure-based peptide inhibitors of Ξ±-synuclein aggregation
granted patentUS 11390667
Compositions and methods for the treatment of neuromyelitis optica
granted patentUS 11382955
Long-acting VEGF inhibitors for intraocular neovascularization
granted patentUS 11382885
Compositions for treating fungal and bacterial biofilms and methods of using the same
granted patentUS 11382890
Prevention of rosacea inflammation
granted patentUS 11384350
Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated kill
granted patentUS 11376346
Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration
granted patentUS 11377646
Modified cells comprising CRISPR systems
granted patentUS 11377451
Compositions and methods for treating cancer
granted